483
Michael E. Gottschalk, M.D.FDA 483 - Michael E. Gottschalk, M.D. - August 05, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Michael E. Gottschalk, M.D., a clinical investigator in San Diego, revealed significant deviations from the investigational plan. Observations included incorrect subject randomization, incomplete physical examinations, missed study visits, and out-of-window visit conduct. Additionally, the firm failed to maintain adequate and accurate case histories, specifically regarding the reporting of adverse events and concomitant medications in eCRFs.
Open in Dashboard
ID · df62ffe9-04fc-4caf-8ef9-fd5c41da372e